Olga Frankfurt is a Hematology physician affiliated with Northwestern University. OpenAlex indexes 155 publications with 6,004 citations (h-index 34); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
675 N Saint Clair St
Suite 21-100
Chicago, IL 606115975
Telephone
312-695-0990Registry record last updated 16 Jul 2009.
Clinical trials
- A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL
Sponsor: Northwestern University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Acrotech Biopharma LLCProgram year20221 payment
- AbbVie Inc.Program year20211 payment
- Servier Pharmaceuticals LLCProgram year20213 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
37.5%Osmotically acting laxatives13.8%Magnesium Sulfate100%Part D<11 patientsProton pump inhibitor11.8%Pantoprazole Sodium100%Part D<11 patients+ 1 more class in this area
Anti-infectives
33.6%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor33.6%Valacyclovir100%Part D≥17 patientsCancer & immunology
28.9%Kinase inhibitor15.1%Jakafi100%Part D<11 patientsSelective immunosuppressants13.8%Rezurock100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Kuzel, MD
Northwestern University
Joel Charrow, MD
Northwestern University
Paul Cremer, MD
Northwestern University
Nisha Mohindra, MD
Northwestern University
Joseph Antin, MD
Boston University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”